Multiples measured against the stock's own five-year history
Near the top of its 5-year range · 100th percentile, 5-year average -26.5x
#2199 of 2974 stocks by PE (1 = cheapest)
Near the top of its 5-year range · 100th percentile, 5-year average 3.0x
#4762 of 5315 stocks by PB (1 = cheapest)
Near the top of its 5-year range · 94th percentile, 5-year average 3.5x
#4256 of 5147 stocks by PS (1 = cheapest)
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 8.49 | – | 3.04 | 100% (pricier than usual) | #4762 of 5315 (1 = cheapest) |
| PE | 33.58 | 251.07 | -26.54 | 100% (pricier than usual) | #2199 of 2974 (1 = cheapest) |
| PS | 7.89 | 7.23 | 3.50 | 94% (pricier than usual) | #4256 of 5147 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on CDNA.